Patents by Inventor Gerrit Dispersyn

Gerrit Dispersyn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9149431
    Abstract: A solid dispersion product comprising itraconazole and hydroxypropyl methylcellulose, which satisfies the Formula 0.35>?Htr (1) (wherein ?Htr represents the endotherm (J/g) accompanying a transition at about 240° C.). The solid dispersion product shows an improved bioavailability.
    Type: Grant
    Filed: June 21, 2013
    Date of Patent: October 6, 2015
    Assignees: Abbvie Deutschland GmbH & Co KG, Barrier Therapeutics, Inc.
    Inventors: Gunther Berndl, Matthias Degenhardt, Markus Mägerlein, Gerrit Dispersyn
  • Publication number: 20140005204
    Abstract: A solid dispersion product comprising itraconazole and hydroxypropyl methylcellulose, which satisfies the Formula 0.35>?Htr (1) (wherein ?Ht, represents the endotherm (J/g) accompanying a transition at about 240° C.). The solid dispersion product shows an improved bioavailability.
    Type: Application
    Filed: June 21, 2013
    Publication date: January 2, 2014
    Inventors: Gunther Berndl, Matthias Degenhardt, Markus Mägerlein, Gerrit Dispersyn
  • Patent number: 8486456
    Abstract: A solid dispersion product comprising itraconazole and hydroxypropyl methylcellulose, which satisfies the Formula 0.35>?Htr (1) (wherein ?Htr represents the endotherm (J/g) accompanying a transition at about 240° C). The solid dispersion product shows an improved bioavailability.
    Type: Grant
    Filed: August 8, 2006
    Date of Patent: July 16, 2013
    Assignee: Abbott GmbH & Co., KG
    Inventors: Gunther Berndl, Matthias Degenhardt, Markus Mäegerlein, Gerrit Dispersyn
  • Publication number: 20090214656
    Abstract: A solid dispersion product comprising itraconazole and hydroxypropyl methylcellulose, which satisfies the Formula 0.35>?Htr (1) (wherein ?Htr represents the endotherm (J/g) accompanying a transition at about 240° C). The solid dispersion product shows an improved bioavailability.
    Type: Application
    Filed: August 8, 2006
    Publication date: August 27, 2009
    Applicants: ABBOTT GMBH & CO. KG, BARRIER THERAPEUTICS
    Inventors: Gunther Berndl, Matthias Degenhardt, Markus Mäegerlein, Gerrit Dispersyn
  • Publication number: 20030198316
    Abstract: Results of a bone mineral density (BMD) measurement and a total score obtained by combining score values pertaining to the applicability of pre-defined risk factors are combined into a value indicating whether a person is at risk of osteoporosis.
    Type: Application
    Filed: April 7, 2003
    Publication date: October 23, 2003
    Inventors: Piet Dewaele, Gerrit Dispersyn